Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.
Source link
Wegovy maker warns of 'painful' price cuts as shares plunge
Review Overview
Summary
Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.
Source link